Mark Fishman

Person

The head of research at Novartis around 2012 who supported the company's work on aging research.

Mentioned in 2 videos

Videos Mentioning Mark Fishman

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

Peter Attia MD

The head of research at Novartis around 2012 who supported the company's work on aging research.

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

Peter Attia MD

Founder of the Novartis Institutes, credited with challenging Lloyd Klickstein and others to explore new areas of drug development, including the biology of aging.